Abstract Background/Aims Immune checkpoint inhibitors (ICIs) are increasingly being used in oncology and there is growing evidence of rheumatological problems arising these group patients. ICIs have been approved for the treatment several cancers including non-small cell lung cancer, renal carcinoma, Hodgkin lymphoma other malignancies. Pembrolizumab, an anti-PD1, known to cause inflammatory ar...

Remitting Seronegative Symmetrical Synovitis with Pitting oedema syndrome, a rare inflammatory arthritis, commonly affects people in the older age group. It can present as an acute onset polyarthritis with associated pitting oedema of the extremities. Patients show excellent response to low dose steroids with complete and sustained remissions. It can also be a paraneoplastic manifestation of an...